241 related articles for article (PubMed ID: 6858844)
1. Relationship between sympathetic neural activity, coronary dynamics, and vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion.
Lombardi F; Verrier RL; Lown B
Am Heart J; 1983 Jun; 105(6):958-65. PubMed ID: 6858844
[TBL] [Abstract][Full Text] [Related]
2. Influence of sympathetic tone on ventricular fibrillation threshold during experimental coronary occlusion.
Kliks BR; Burgess MJ; Abildskov JA
Am J Cardiol; 1975 Jul; 36(1):45-9. PubMed ID: 1146697
[TBL] [Abstract][Full Text] [Related]
3. Pericardial prostaglandin biosynthesis prevents the increased incidence of reperfusion-induced ventricular fibrillation produced by efferent sympathetic stimulation in dogs.
Miyazaki T; Zipes DP
Circulation; 1990 Sep; 82(3):1008-19. PubMed ID: 2118429
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of verapamil on vulnerability to ventricular fibrillation during myocardial ischaemia and reperfusion.
Brooks WW; Verrier RL; Lown B
Cardiovasc Res; 1980 May; 14(5):295-302. PubMed ID: 7388861
[TBL] [Abstract][Full Text] [Related]
5. Cardiac sympathetic nervous activity during myocardial ischemia, reperfusion and ventricular fibrillation in the dog--effects of intravenous lidocaine.
Aidonidis I; Brachmann J; Seller H; Demowsky K; Czachurski J; Kübler W
Cardiology; 1992; 80(3-4):196-204. PubMed ID: 1511466
[TBL] [Abstract][Full Text] [Related]
6. Vulnerability to ventricular fibrillation during acute coronary arterial occlusion and release.
Axelrod PJ; Verrier RL; Lown B
Am J Cardiol; 1975 Nov; 36(6):776-82. PubMed ID: 1199933
[TBL] [Abstract][Full Text] [Related]
7. Effect of nitroglycerin on vulnerability to ventricular fibrillation during myocardial ischemia and reperfusion.
Stockman MB; Verrier RL; Lown B
Am J Cardiol; 1979 Feb; 43(2):233-8. PubMed ID: 104608
[TBL] [Abstract][Full Text] [Related]
8. Acute blood pressure elevation and ventricular fibrillation threshold during coronary occlusion and reperfusion in the dog.
Blatt CM; Verrier RL; Lown B
Am J Cardiol; 1977 Apr; 39(4):523-8. PubMed ID: 848436
[TBL] [Abstract][Full Text] [Related]
9. Differing mechanisms for ventricular vulnerability during coronary artery occlusion and release.
Corbalan R; Verrier RL; Lown B
Am Heart J; 1976 Aug; 92(2):223-30. PubMed ID: 941834
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiologic actions and antifibrillatory efficacy of subacute left stellectomy in a conscious, post-infarction canine model of ischemic ventricular fibrillation.
Nelson SD; Lynch JJ; Sanders D; Montgomery DG; Lucchesi BR
Int J Cardiol; 1989 Mar; 22(3):365-76. PubMed ID: 2707916
[TBL] [Abstract][Full Text] [Related]
11. Left stellectomy in the prevention of ventricular fibrillation caused by acute myocardial ischemia in conscious dogs with anterior myocardial infarction.
Schwartz PJ; Stone HL
Circulation; 1980 Dec; 62(6):1256-65. PubMed ID: 7438361
[TBL] [Abstract][Full Text] [Related]
12. Single cardiac vagal fiber activity, acute myocardial ischemia, and risk for sudden death.
Cerati D; Schwartz PJ
Circ Res; 1991 Nov; 69(5):1389-401. PubMed ID: 1934362
[TBL] [Abstract][Full Text] [Related]
13. [Comparative studies on the anti-arrhythmic and anti-fibrillatory effectiveness of verapamil and nifedipine following acute coronary artery occlusion and reperfusion].
Gülker H; Thale J; Brisse B; Bender F
Z Kardiol; 1984 Aug; 73(8):515-24. PubMed ID: 6495811
[TBL] [Abstract][Full Text] [Related]
14. Cardiac sympathetic innervation via middle cervical and stellate ganglia and antiarrhythmic mechanism of bilateral stellectomy.
Irie T; Yamakawa K; Hamon D; Nakamura K; Shivkumar K; Vaseghi M
Am J Physiol Heart Circ Physiol; 2017 Mar; 312(3):H392-H405. PubMed ID: 28011590
[TBL] [Abstract][Full Text] [Related]
15. Activation of cardiac sympathetic afferents during coronary occlusion. Evidence for reflex activation of sympathetic nervous system during transmural myocardial ischemia in the dog.
Minisi AJ; Thames MD
Circulation; 1991 Jul; 84(1):357-67. PubMed ID: 2060106
[TBL] [Abstract][Full Text] [Related]
16. Antiarrhythmic and antifibrillatory action of diltiazem on early and late phase ventricular arrhythmias following coronary artery occlusion and on reperfusion ventricular arrhythmias.
Thale J; Gülker H; Olbing B; Rose D; Bender F
Pharmacology; 1986; 33(1):1-13. PubMed ID: 3737671
[TBL] [Abstract][Full Text] [Related]
17. Effects of unilateral cardiac sympathetic denervation on the ventricular fibrillation threshold.
Schwartz PJ; Snebold NG; Brown AM
Am J Cardiol; 1976 Jun; 37(7):1034-40. PubMed ID: 1274864
[TBL] [Abstract][Full Text] [Related]
18. Neural and psychologic mechanisms and the problem of sudden cardiac death.
Lown B; Verrier RL; Rabinowitz SH
Am J Cardiol; 1977 May; 39(6):890-902. PubMed ID: 860697
[TBL] [Abstract][Full Text] [Related]
19. Ventricular arrhythmias following one-stage and two-stage coronary reperfusion: evidence for both reentry and enhanced automaticity.
Kabell G; Scherlag BJ; Brachmann J; Harrison L; Lazzara R
J Electrocardiol; 1985 Jan; 18(1):87-96. PubMed ID: 2579181
[TBL] [Abstract][Full Text] [Related]
20. Comparative effects of the opioids fentanyl and buprenorphine on ventricular vulnerability during acute coronary artery occlusion.
Saini V; Carr DB; Verrier RL
Cardiovasc Res; 1989 Dec; 23(12):1001-6. PubMed ID: 2559806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
